Opciones de tratamiento de la Enfermedad de Hodgkin

Written by: Dr. Jesús Alcaraz Rubio
Edited by: Top Doctors®

Current treatment plans for Hodgkin lymphoma use new types and doses of chemotherapy and radiation therapy directed to smaller areas of the body.

Most people with classic Hodgkin's lymphoma, even stage I or II, often receive chemotherapy followed by radiation therapy in the areas of affected lymph nodes. For stage III or IV disease, chemotherapy is the primary treatment, although additional radiation therapy may be recommended, especially in areas of large lymph nodes.

Treatment options and recommendations depend on a number of factors, including the type and stage of the cancer, possible side effects, the results of the explorations during treatment, as well as the patient's preferences and general health.

Your care plan may also include treatment for symptoms and side effects, an important part of cancer care.

Available Techniques to Fight Hodgkin's Disease

The three main treatments are: chemotherapy, radiation therapy and bone marrow or stem cell transplantation.

Patients who have received treatment for Hodgkin lymphoma are at increased risk of developing other diseases or conditions in the future, since chemotherapy and radiation therapy can cause permanent damage. Treatments have improved in recent years, and patients are now less likely to have late effects. However, there are still some risks. Therefore, it is important that patients regularly visit their specialists for their follow-up care in order to control any side effects.

Some of the side effects to treatment might be: infertility, secondary cancer, lung and heart damage, thyroid problems, and emotional problems.


Patients with Hodgkin's disease are susceptible to other pathologies


What's New in Hodgkin's Disease Research

Hematology specialists are working to learn more about Hodgkin lymphoma, how to prevent it, what is the best treatment and how to provide the best care to people diagnosed with Hodgkin lymphoma. It is advisable to always talk to the doctor about the best diagnostic and treatment options for each case. The novelties are:

- Determination of treatment effectiveness

- New Chemotherapy / Targeted Therapy

- Immunotherapy

- Genetic Description

- Other treatments

- Reduction of treatment intensity

- Palliative care

*Translated with Google translator. We apologize for any imperfection

By Dr. Jesús Alcaraz Rubio

Dr. Alcaraz Rubio is a recognized specialist in Hematology with years of experience in the profession. It is optional in the Hematology and Hemotherapy area of ​​various hospitals and medical centers. In addition, he has taken doctoral courses and obtained the investigative sufficiency. He is an expert in anemia, chronic lymphatic leukemia, Hodgkin's disease, regenerative medicine and coagulation disorders. He is member of the Spanish group of Aggressive Lymphomas and hematopoietic therapy GELTAMO. On the other hand, he is the author of many national and international articles on the use of platelet and plasma growth factors. He is a member of the Spanish Society of Hematology and the American Society of Hematology. He is a member of the Spanish society of thrombosis and hemostasis. He is also a member of scientific review committees, as well as the editorial team of prestigious journals in the specialty. He is the author of the book "Regenerative Medicine and the secret of Plasma rich in Plaquetas", of the Spanish academic publishing house. He combines his work with teaching, being tutor of practices of students of 3rd year of Medicine in the subject of general pathology of the Catholic University of Murcia, as well as co-director of various courses related to the specialty for residents and specialists specialists and coordinator of The Hematologiasite platform for the development and dissemination of hematology worldwide through Wordpress.

*Translated with Google translator. We apologize for any imperfection

View Profile

Overall assessment of their patients

TOPDOCTORS utiliza cookies propias y de terceros para facilitar su experiencia como usuario de nuestra web y captar datos estadísticos mediante el análisis de sus datos de navegación. Si usted continúa con la navegación, entendemos que nos ofrece su consentimiento para el uso de cookies. Puede cambiar la configuración de cookies u obtener más información here.